C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/519 (2006.01) A61P 19/00 (2006.01)
Patent
CA 2608890
The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP- 13 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP- 13 inhibitors.
La présente invention concerne d'une manière générale des agents pharmaceutiques contenant un groupe amide et, en particulier, des composés inhibiteurs de métalloprotéase hétérobicyclique contenant un amide. Cette invention concerne plus particulièrement une nouvelle classe de composés inhibiteurs MMP-13 hétérobicycliques qui présente une puissance améliorée par rapport aux inhibiteurs MMP- 13 connus jusqu'à présent.
Bluhm Harald
Boer Jurgen
Deng Hongbo
Essers Michael
Feurstein Tim
Alantos Pharmaceuticals Holding Inc.
Alantos-Pharmaceuticals Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Heterobicyclic metalloprotease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterobicyclic metalloprotease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterobicyclic metalloprotease inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2078402